Atlas Trials

A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

Clinical trial NCT05806138 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05806138
Sponsor
Memorial Sloan Kettering Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerCardiac Dysfunction
Start date
2023-07-17
Primary completion
2028-07-17
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.